NIH-funded research R01 grant

Understanding how insulin is cleared from the body

Official title: Novel Molecular Determinants of Insulin Clearance

Funded at Western University of Health Sciences · NIH-11018537 · Data updated 2026-11-12

This study is looking at how the body gets rid of insulin from the blood, especially for people with Type 2 diabetes, to find new ways to help manage insulin levels and improve overall health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWestern University of Health Sciences
NIH-funded
Lab location1 site (Pomona, United States)
Project startApril 25, 2022
Project endJanuary 31, 2026
Funding year2025
Award (this year)$477,742
NIH project number5R01DK129877-04
Project IDNIH-11018537 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Type 2 diabetes who may be experiencing issues with insulin regulation.

Less likely to help

Patients without Type 2 diabetes or those with other forms of diabetes may not benefit from this research.

What this research studies

This research investigates the molecular factors that influence how insulin is cleared from the bloodstream, particularly in the context of Type 2 diabetes (T2D). It aims to explore the cellular mechanisms behind insulin clearance and how they relate to insulin resistance and secretion. By studying these processes, the research seeks to uncover potential new therapeutic targets that could improve insulin regulation and overall metabolic health for patients with T2D.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance insulin clearance, potentially improving blood sugar control and reducing complications associated with Type 2 diabetes.

How similar studies have gone: While insulin clearance has been less studied compared to insulin secretion and resistance, there is emerging evidence suggesting that understanding this area could lead to significant advancements in diabetes treatment.

Where this research is happening

  • Western University of Health Sciences
    Pomona, United States
    Active

Researchers

  • Principal investigator: Peterfy, Miklos — Western University of Health Sciences
  • Study coordinator: Peterfy, Miklos

Related research

Other NIH-funded projects on the same topics.

  • HIV blocks immune alarm signals by targeting IPS-1 to weaken interferon responses

    A study in people with HIV explores how the virus disrupts a key alarm system (interferon) by manipulating a molecule called IPS-1 to help the virus hide and replicate.

    NIH research Western University of Health Sciences · Pomona, United States · NIH-11411774

  • Cooperative Modulation of Piezo Channels and Heart Health

    A study to understand how PIEZO channels in heart and blood vessels respond to mechanical forces and how their behavior might contribute to conditions like hypertension and cardiomyopathy.

    NIH research Western University of Health Sciences · Pomona, United States · NIH-11376571

  • Protein Kinase R and hantavirus organ targeting in humans

    Researchers are studying how PKR and related proteins influence where hantaviruses attack in the body, which could lead to better protection against kidney and heart/lung damage in people exposed to these viruses.

    NIH research Western University of Health Sciences · Pomona, United States · NIH-11358667

  • Noncanonical DNA virus sensing through IKK-alpha–driven interferon signaling

    Researchers are exploring a new pathway by which the body detects DNA from viruses and triggers protective interferon responses, which could lead to better treatments for viral infections.

    NIH research Western University of Health Sciences · Pomona, United States · NIH-11356021

  • Preventing UV-driven skin cancer with a skin-targeted form of R-carvedilol

    A patient-friendly look at a cancer-prevention approach using a skin-targeted version of R-carvedilol to block UV-driven skin cancer without affecting heart health.

    NIH research Western University of Health Sciences · Pomona, United States · NIH-11353903

  • Pharmacological modulation of Piezo1 channels

    A new NIH grant is exploring how to control Piezo1 ion channels with drugs to treat diseases linked to mechanical sensing in the body.

    NIH research Western University of Health Sciences · Pomona, United States · NIH-11331293

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.